Skip to main content

Advertisement

SpringerLink
Log in

Pathogenesis of pain in peripheral diabetic neuropathy

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Recent advances in understanding the pain associated with diabetic neuropathy are likely to provide significant mechanistic insights and offer better therapies. In clinical research, new tools for measuring neuropathic pain and validation of histologic and other biomarkers will provide the foundation for research advances, and new clinical trial designs will allow better discrimination of beneficial treatments and may reveal underlying pathogenic mechanisms. Ongoing refinement of relevant animal models and assays to more accurately reflect the clinical condition will improve evaluation of novel pharmacologic approaches while dissecting peripheral versus central effects of diabetes on pain pathways will provide a more complete picture of the pathophysiologic mechanisms. Such multidisciplinary work may soon allow physicians to offer improved therapeutic options to patients suffering this distressing condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jensen TS, Backonja MM, Hernandez Jimenez S, et al.: New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006, 3:108–119.

    Article  PubMed  Google Scholar 

  2. Ji RR, Strichartz G: Cell signaling and the genesis of neuropathic pain. Sci STKE 2004, 2004(252):reE14.

    PubMed  Google Scholar 

  3. Backonja MM, Galer B: Pain assessment and evaluation of patients with neuropathic pain. Neurol Clin 1998, 16:775–790.

    Article  PubMed  CAS  Google Scholar 

  4. Woolf CJ, Mannion RJ: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959–1964.

    Article  PubMed  CAS  Google Scholar 

  5. Kelly Getz K, Cook T, Backonja MM: Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Muscle Nerve 2005, 32:179–184.

    Article  Google Scholar 

  6. Rolke R, Baron R, Maier C, et al.: Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006, 123:231–243.

    PubMed  CAS  Google Scholar 

  7. Yarnitsky D, Sprecher E: Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 1994, 125:39–45.

    Article  PubMed  CAS  Google Scholar 

  8. Dyck PJ, O’Brien PC: Approaches to quantitative cutaneous sensory assessment. In Quantification of Neurologic Deficits. Edited by Munsat TL. Boston: Butterworths; 1997:187–195.

    Google Scholar 

  9. Harju EL: Cold and warmth perception mapped for age, gender, and body area. Somatosens Mot Res 2002, 19:61–75.

    Article  PubMed  Google Scholar 

  10. Bennett MI, Attal N, Backonja MM, et al.: Using screening tools to identify neuropathic pain. Pain 2007, 127:199–203.

    Article  PubMed  Google Scholar 

  11. Bennett MI: The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001, 92:147–157.

    Article  PubMed  CAS  Google Scholar 

  12. Backonja M, Krause S: Neuropathic pain questionnaire-short form. Clin J Pain 2003, 19:315–316.

    Article  PubMed  Google Scholar 

  13. Bouhassira D, Attal N, Alchaar H, et al.: Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005, 14:29–36.

    Article  Google Scholar 

  14. Freynhagen R, Baron R, Gockel U, Tolle TR: painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006, 22:1911–1120.

    Article  PubMed  Google Scholar 

  15. Krause S, Backonja M: Development of a neuropathic pain questionnaire. Clin J Pain 2003, 19:306–314.

    Article  PubMed  Google Scholar 

  16. Bouhassira D, Attal N, Fermanian J, et al.: Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004, 108:248–257.

    Article  PubMed  Google Scholar 

  17. Lauria G, Lombardi R: Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ 2007, 334:1159–1162.

    Article  PubMed  Google Scholar 

  18. Walk D, Wendelschafer-Crabb G, Davey C, Kennedy W: Concordance between epidermal nerve fiber density and sensory examination in patients with symptoms of idiopathic small fiber neuropathy. J Neurol Sci 2007, 255:23–26.

    Article  PubMed  Google Scholar 

  19. Gibbons CH, Griffin JW, Polydefkis M, et al.: The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006, 66:256–258.

    Article  PubMed  CAS  Google Scholar 

  20. Uceyler N, Rogausch JP, Toyka KV, Sommer C: Differential expression of cytokines in painful and painless neuropathies. Neurology 2007, 69:42–49.

    Article  PubMed  CAS  Google Scholar 

  21. Quattrini C, Harris ND, Malik RA, Tesfaye S: Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 2007, 30:655–659.

    Article  PubMed  Google Scholar 

  22. Malik RA, Kallinikos P, Abbott CA, et al.: Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003, 46:683–688.

    PubMed  CAS  Google Scholar 

  23. Quattrini C, Tavakoli M, Jeziorska M, et al.: Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007, 56:2148–2154.

    Article  PubMed  CAS  Google Scholar 

  24. Wernicke JF, Pritchett YL, D’souza DN, et al.: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006, 67:1411–1420.

    Article  PubMed  CAS  Google Scholar 

  25. Raskin J, Pritchett YL, Wang F, et al.: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005, 6:346–356.

    Article  PubMed  Google Scholar 

  26. Richter RW, Portenoy R, Sharma U, et al.: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain 2005, 6:253–260.

    Article  PubMed  CAS  Google Scholar 

  27. Lesser H, Sharma U, LaMoreaux L, Poole RM: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004, 63:2104–2110.

    PubMed  CAS  Google Scholar 

  28. Backonja MM, Irving GA, Argoff CE: Rational multidrug therapy in the treatment of neuropathic pain. Curr Pain Headache Rep 2006, 10:34–38.

    Article  PubMed  Google Scholar 

  29. Gilron I, Bailey JM, Tu D, et al.: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324–1334.

    Article  PubMed  CAS  Google Scholar 

  30. Christianson JA, Ryals JM, Johnson MS, et al.: Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 2007, 145:303–313.

    Article  PubMed  CAS  Google Scholar 

  31. Johnson MS, Ryals JM, Wright DE: Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice. J Pain 2007, 8:637–649.

    Article  PubMed  CAS  Google Scholar 

  32. Kamiya H, Murakawa Y, Zhang W, Sima AA: Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes. Diabetes Metab Res Rev 2005, 21:448–458.

    Article  PubMed  CAS  Google Scholar 

  33. Kamiya H, Zhang W, Ekberg K, et al.: C-Peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes 2006, 55:3581–3587.

    Article  PubMed  CAS  Google Scholar 

  34. Zhang W, Murakawa Y, Wozniak KM, et al.: The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy. J Neurol Sci 2006, 247:217–223.

    Article  PubMed  CAS  Google Scholar 

  35. Drel VR, Mashtalir N, Ilnytska O, et al.: The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 2006, 55:3335–3343.

    Article  PubMed  CAS  Google Scholar 

  36. Li F, Abatan OI, Kim H, et al.: Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 2006, 22:669–676.

    Article  PubMed  CAS  Google Scholar 

  37. Vareniuk I, Pavlov IA, Drel VR, et al.: Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007, 205:425–436.

    Article  PubMed  CAS  Google Scholar 

  38. Jourdan D, Ardid D, Eschalier A: Analysis of ultrasonic vocalisation does not allow chronic pain to be evaluated in rats. Pain 2002, 95:165–173.

    Article  PubMed  Google Scholar 

  39. Han JS, Bird GC, Li W, et al.: Computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior. J Neurosci Methods 2005, 141:261–269.

    Article  PubMed  Google Scholar 

  40. Morgado C, Tavares I: C-fos expression at the spinal dorsal horn of streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2007, May 16; [Epub ahead of print].

  41. Otto M, Bak S, Bach FW, et al.: Pain phenomena and possible mechanisms in patients with painful polyneuropathy. Pain 2003, 101:187–192.

    Article  PubMed  Google Scholar 

  42. Calcutt NA: Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 2002, 50:205–228.

    Article  PubMed  CAS  Google Scholar 

  43. Beyreuther B, Callizot N, Stohr T: Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy. Eur J Pharmacol 2006, 539:64–70.

    Article  PubMed  CAS  Google Scholar 

  44. Jolivalt CG, Ramos KM, Herbetsson K, et al.: Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Pain 2006, 121:14–21.

    Article  PubMed  CAS  Google Scholar 

  45. Jolivalt CG, Jiang Y, Freshwater JD, et al.: Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia 2006, 49:2775–2285.

    Article  PubMed  CAS  Google Scholar 

  46. Joseph EK, Levine JD: Mitochondrial electron transport in models of neuropathic and inflammatory pain. Pain 2006, 121:105–114.

    Article  PubMed  CAS  Google Scholar 

  47. Sanchez-Ramirez GM, Caram-Salas NL, Rocha-Gonzalez HI, et al.: Benfotiamine relieves inflammatory and neuropathic pain in rats. Eur J Pharmacol 2006, 530:48–53.

    Article  PubMed  CAS  Google Scholar 

  48. Aubel B, Kayser V, Farre A, et al.: Evidence for adenosine-and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy. Neuropharmacology 2007, 52:487–496.

    Article  PubMed  CAS  Google Scholar 

  49. Khroyan TV, Polgar WE, Orduna J, et al.: Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents. Eur J Pharmacol 2007, 560:29–35.

    Article  PubMed  CAS  Google Scholar 

  50. Matsunaga A, Kawamoto M, Shiraishi S, et al.: Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Eur J Pharmacol 2007, 554:12–17.

    Article  PubMed  CAS  Google Scholar 

  51. Ramos KM, Jiang Y, Svensson CI, Calcutt NA: Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes 2007, 56:1569–1576.

    Article  PubMed  CAS  Google Scholar 

  52. Torres-Lopez JE, Juarez-Rojop IE, Granados-Soto V, et al.: Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats. Neuropharmacology 2007, 52:788–795.

    Article  PubMed  CAS  Google Scholar 

  53. Daulhac L, Mallet C, Courteix C, et al.: Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol Pharmacol 2006, 70:1246–1254.

    Article  PubMed  CAS  Google Scholar 

  54. Ilnytska O, Lyzogubov VV, Stevens MJ, et al.: Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 2006, 55:1686–1694.

    Article  PubMed  CAS  Google Scholar 

  55. Inkster ME, Cotter MA, Cameron NE: Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur J Pharmacol 2007, 561:63–71.

    Article  PubMed  CAS  Google Scholar 

  56. Kumar A, Kaundal RK, Iyer S, Sharma SS: Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 2007, 80:1236–1244.

    Article  PubMed  CAS  Google Scholar 

  57. Stevens MJ, Li F, Drel VR, et al.: Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J Pharmacol Exp Ther 2007, 320:458–464.

    Article  PubMed  CAS  Google Scholar 

  58. Calcutt NA, Freshwater JD, Mizisin AP: Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004, 47:718–724.

    Article  PubMed  CAS  Google Scholar 

  59. Romanovsky D, Cruz NF, Dienel GA, Dobretsov M: Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats. Neurobiol Dis 2006, 24:384–394.

    Article  PubMed  CAS  Google Scholar 

  60. Hoybergs YM, Meert TF: The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy. Neurosci Lett 2007, 417:149–154.

    Article  PubMed  CAS  Google Scholar 

  61. Toth C, Brussee V, Zochodne DW: Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 2006, 49:1081–1088.

    Article  PubMed  CAS  Google Scholar 

  62. Huang TJ, Price SA, Chilton L, et al.: Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 2003, 52:2129–2136.

    Article  PubMed  CAS  Google Scholar 

  63. Wang XL, Zhang HM, Chen SR, Pan HL: Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol 2007, 579:849–861.

    Article  PubMed  CAS  Google Scholar 

  64. Malmberg AB, O’Connor WT, Glennon JC, et al.: Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats. Brain Res 2006, 1115:48–53.

    Article  PubMed  CAS  Google Scholar 

  65. Tanabe M, Shimizu S, Takabayashi K, et al.: Functional alteration of inhibitory influences on spinal motor output in painful diabetic neuropathy in rats. Neurosci Lett 2005, 389:152–156.

    Article  PubMed  CAS  Google Scholar 

  66. Calcutt NA, Li L, Yaksh TL, Malmberg AB: Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur J Pharmacol 1995, 285:189–197.

    Article  PubMed  CAS  Google Scholar 

  67. Freshwater JD, Svensson CI, Malmberg AB, Calcutt NA: Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 2002, 51:2249–2255.

    Article  PubMed  CAS  Google Scholar 

  68. Jiang Y, Calcutt NA, Ramos KM, Mizisin AP: Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J Peripher Nerv Syst 2006, 11:274–285.

    Article  PubMed  CAS  Google Scholar 

  69. Waxman SG, Hains BC: Fire and phantoms after spinal cord injury: Na+ channels and central pain. Trends Neurosci 2006, 29:207–215.

    Article  PubMed  CAS  Google Scholar 

  70. Flor H, Nikolajsen L, Staehelin Jensen T: Phantom limb pain: a case of maladaptive CNS plasticity? Nat Rev Neurosci 2006, 7:873–881.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Wisconsin — Madison, 600 Highland Avenue, Madison, WI, 53792, USA

    Miroslav Misha Backonja

Authors
  1. Nigel A. Calcutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miroslav Misha Backonja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Miroslav Misha Backonja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calcutt, N.A., Backonja, M.M. Pathogenesis of pain in peripheral diabetic neuropathy. Curr Diab Rep 7, 429–434 (2007). https://doi.org/10.1007/s11892-007-0072-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-007-0072-9

Keywords

Search

Navigation